Dorman Followwill

Insider Reports History

Entity
Individual
Location
C/O Sorrento Therapeutics, Inc., 4955 Director's Place, San Diego, CA
Signature
/s/ Jaisim Shah, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dorman Followwill:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Scilex Holding Co Director Common Stock 2.3K $2.28K $0.99 Oct 18, 2024 Direct
Sorrento Therapeutics, Inc. Director Stock option (right to buy) 250K Aug 30, 2021 Direct
Scilex Holding Co Director Nonstatutory Stock Option (right to buy) 100K Dec 16, 2024 Direct

Insider Reports Filed by Dorman Followwill

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SCLX Scilex Holding Co Dec 16, 2024 1 $0 4 Dec 17, 2024 Director
SCLX Scilex Holding Co Oct 18, 2024 1 $990 4 Oct 18, 2024 Director
SCLX Scilex Holding Co Jun 26, 2024 2 $1.37K 4 Jun 26, 2024 Director
SCLX Scilex Holding Co Mar 15, 2024 1 $0 4 Jun 26, 2024 Director
SCLX Scilex Holding Co Jan 17, 2023 1 $0 4 Jan 17, 2023 Director
SCLX Vickers Vantage Corp. I Nov 10, 2022 0 $0 3 Nov 15, 2022 Director
SRNEQ Sorrento Therapeutics, Inc. Aug 30, 2021 1 $0 4 Aug 30, 2021 Director